Malonic Acid → Bis(2,2,6,6-tetramethyl-4-piperidyl) succinate

HRID 840406

Reaktionsgleichung

Reaktionsgleichung von HRID 840406
C(OC1CC(C)(C)NC(C)(C)C1)(=O)CCCCC[CH2:7][CH2:8][CH2:9][C:10]([O:12][CH:13]1[CH2:18][C:17]([CH3:20])([CH3:19])[NH:16][C:15]([CH3:22])([CH3:21])[CH2:14]1)=[O:11].C(OC1CC(C)(C)N(C)C(C)(C)C1)(=O)CCCCCCCCC([O:46][CH:47]1[CH2:52][C:51]([CH3:54])([CH3:53])[N:50](C)[C:49]([CH3:57])([CH3:56])[CH2:48]1)=O.C(OC1CC(C)(C)N(OCCCCCCCC)C(C)(C)C1)(=O)CCCCCCCCC(OC1CC(C)(C)N(OCCCCCCCC)C(C)(C)C1)=[O:81].C(C(CC1C=C(C(C)(C)C)C(O)=C(C(C)(C)C)C=1)(C(OC1CC(C)(C)N(C)C(C)(C)C1)=O)C(OC1CC(C)(C)N(C)C(C)(C)C1)=O)CCC.C(OC1CC(C)(C)N(OCCCCCCCC)C(C)(C)C1)(=O)C(C)=C.OCCNC1N=C(C2C(NCCCC)CC(C)(C)N(C)C2(C)C)N=C(C2C(NCCCC)CC(C)(C)N(C)C2(C)C)N=1.C(C(OC1CC(C)(C)NC(C)(C)C1)=O)C(C(OC1CC(C)(C)NC(C)(C)C1)=O)C(C(OC1CC(C)(C)NC(C)(C)C1)=O)CC(OC1CC(C)(C)NC(C)(C)C1)=O.C(C(OC1CC(C)(C)N(C)C(C)(C)C1)=O)C(C(OC1CC(C)(C)N(C)C(C)(C)C1)=O)C(C(OC1CC(C)(C)N(C)C(C)(C)C1)=O)CC(OC1CC(C)(C)N(C)C(C)(C)C1)=O.C(C1CC(=O)N(C2CC(C)(C)NC(C)(C)C2)C1=O)CCCCCCCCCCC.C(C1CC(=O)N(C2CC(C)(C)N(C(=O)C)C(C)(C)C2)C1=O)CCCCCCCCCCC.C(O)(=O)CC(O)=O>>[C:10]([O:12][CH:13]1[CH2:14][C:15]([CH3:21])([CH3:22])[NH:16][C:17]([CH3:19])([CH3:20])[CH2:18]1)(=[O:11])[CH2:9][CH2:8][C:7]([O:46][CH:47]1[CH2:48][C:49]([CH3:57])([CH3:56])[NH:50][C:51]([CH3:54])([CH3:53])[CH2:52]1)=[O:81]

Komponenten

12

Versuchsvorschrift

bis(2,2,6,6-tetramethylpiperid-4-yl) sebacate; bis(1,2,2,6,6-pentamethylpiperid-4-yl) sebacate; bis(1-octyloxy-2,2,6,6-tetramethylpiperid-4-yl) sebacate; di(1,2,2,6,6-pentamethylpiperid-4-yl) 2-n-butyl-2-(3,5-di-tert-butyl-4-hydroxybenzyl)malonate; 1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl methacrylate; 2-(2-hydroxyethylamino)-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidyl)-1,3,5-triazine; tetra(2,2,6,6-tetramethylpiperid-4-yl) butane-1,2,3,4-tetracarboxylate; tetra(1,2,2,6,6-pentamethylpiperid-4-yl) butane-1,2,3,4-tetracarboxylate; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxo-dispiro[5.1.11.2]heneicosane; 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione; 3-dodecyl-1-(1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidin-2,5-dione, propanedioic acid, [(4-methoxyphenyl)methylene]-, bis(1,2,2,6,6-pentamethyl-4-piperidinyl) ester; propanedioic acid, [(4-methoxyphenyl)methylene]-, bis(1-acetyl-2,2,6,6-pentamethyl-4-piperidinyl) ester.

Quellen und Nachweise

ORD-Eintrag
ord-f8e86ca57076435db71ffebcc4f0c506
Quelldatensatz
uspto-grants-2002_04
Patentnummer
US06365652B2

Verknüpfte Notizen

Wird geladen…